AbstractObjective To evaluate the effect of radical image-guided radiotherapy (IGRT) on the target dose in cervical cancer and investigate the appropriate application mode. Methods Twenty patients with cervical cancer treated with helical tomotherapy (HT) in Seventh Medical Center of PLA General Hospital from 2012 to 2016 were selected. A megavoltage CT (MVCT) scan was performed before each treatment. The obtained MVCT images were used for dose parameter in the adaptive module of HT to obtain the actual dose (Plan 1) and the non-image-guided dose parameter was simulated (Plan 2). Each single dose distribution and the corresponding fused CT images were transferred to the software Mimvista 6.5 to obtain the total radiation dose parameter by dose superposition. Results The motion of CTV,uterus and GTV in Plan 2 was significantly larger than that of Plan 1(all P<0.05), and the largest changes were seen in the ventrodorsal and uterine direction. The V45Gy, V50Gy, D98% and Dmean of CTV and uterus and V50Gy of GTV in Plan 2 were significantly decreased compared with those in Plan 1(all P<0.05). The left-right motion of Plan 1 was negatively correlated with D2% and D98% of CTV and uterus (both P<0.05). The head-foot motion was negatively associated with V45Gy and V50Gy of GTV (both P<0.05). The ventrodorsal motion was negatively correlated with D98% of uterus (P<0.05). The left-right motion of Plan 2 was negatively correlated with D2% of CTV and V50Gy of uterus (both P<0.05). The head-foot motion was negatively associated with D98% of CTV, and D98%, Dmean, V45Gy and V50Gy of uterus (all P<0.05). The ventrodorsal motion was negatively correlated with D98% of CTV,D98%, Dmean, V45Gy and V50Gy of uterus, and Dmean and V45Gy of GTV (all P<0.05). Conclusions In intensity-modulated radiotherapy for cervical cancer, the uterine body displacement is large and the low CTV area is mainly located in the uterine body. IGRT can significantly reduce the dosimetric deviation induced by organ movement.
Corresponding Authors:
Wang Yadi, Email:wangyadi@hotmail.com
Cite this article:
Lu Na,Zhang Zongkai,Wang Yadi et al. The impact of image-guided radiation therapy on treatment of cervical cancer[J]. Chinese Journal of Radiation Oncology, 2021, 30(1): 81-85.
Lu Na,Zhang Zongkai,Wang Yadi et al. The impact of image-guided radiation therapy on treatment of cervical cancer[J]. Chinese Journal of Radiation Oncology, 2021, 30(1): 81-85.
[1] Forrest J, Presutti J, Davidson M, et al. A dosimetric planning study comparing intensity-modulated radiotherapy with four-field conformal pelvic radiotherapy for the definitive treatment of cervical carcinoma[J]. Clin Oncol, 2012, 24(4):e63-70. DOI:10.1016/j.clon.2011.06.008. [2] Roeske JC, Lujan A, Rotmensch J, et al. Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies[J]. Int J Radiat Oncol Biol Phys, 2000, 48(5):1613-1621. DOI:10.1016/s03603016(00)0071-9. [3] Portelance L, Chao KS, Grigsby PW, et al. Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation[J]. Int J Radiat Oncol Biol Phys, 2001, 51(1):261-266. DOI:10.1016/s0360-3016(01)01554-9. [4] Cozzi L, Dinshaw KA, Shrivastava SK, et al. A treatment planning study comparing volumetric arc modulation with RapidArc and fixed field IMRT for cervix uteri radiotherapy[J]. Radiother Oncol, 2008, 89(2):180-191. DOI:10.1016/j.radonc.2008.06.013. [5] Jadon R, Pembroke CA, Hanna CL, et al. A systematic review of organ motion and image-guided strategies in external beam radiotherapy for cervical cancer[J]. Clin Oncol, 2014, 26(4):185-196. DOI:10.1016/j.clon.2013.11.031. [6] Lim K, Small WJ, Portelance L, et al. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer[J]. Int J Radiat Oncol Biol Phys, 2011, 79(2):348-355. DOI:10.1016/j.ijrobp.2009.10.075. [7] Tyagi N, Lewis JH, Yashar CM, et al. Daily online cone beam computed tomography to assess interfractional motion in patients with intact cervical cancer[J]. Int J Radiat Oncol Biol Phys, 2011, 80(1):273-280. DOI:10.1016/j.ijrobp.2010.06.003. [8] Herrera FG, Callaway S, Delikgoz-Soykut E, et al. Retrospective feasibility study of simultaneous integrated boost in cervical cancer using tomotherapy:the impact of organ motion and tumor regression[J]. Radiat Oncol, 2013, 8:5. DOI:10.1186/1748-717X-8-5. [9] Chan P, Dinniwell R, Haider MA, et al. Inter-and intrafractional tumor and organ movement in patients with cervical cancer undergoing radiotherapy:a cinematic-MRI point-of-interest study[J]. Int J Radiat Oncol Biol Phys, 2008, 70(5):1507-1515. DOI:10.1016/j.ijrobp.2007.08.055. [10] 李奕彤,王雅棣,张富利,等. 宫颈癌调强放疗中靶区变化与剂量分析[J]. 中华放射医学与防护杂志, 2015, 35(10):751-755. DOI:10.3760/cma.j.issn.0254-5098.2015.10.007. Li YT, Wang YD, Zhang FL, et al. Variation of organ position and dose for cervical cancer patients treated with helical tomotherapy[J]. Chin J Radiol Med Prot, 2015, 35(10):751-755. DOI:10.3760/cma.j.issn.0254-5098.2015.10.007. [11] Eminowicz G, Rompokos V, Stacey C, et al. Understanding the impact of pelvic organ motion on dose delivered to target volumes during IMRT for cervical cancer[J]. Radiother Oncol, 2017, 122(1):116-121. DOI:10.1016/j.radonc.2016.10.018. [12] Plante M. Vaginal radical trachelectomy:an update[J]. Gynecol Oncol, 2008, 111(2 Suppl):S105-110. DOI:10.1016/j.ygyno.2008.07.020. [13] Haripotepornkul NH, Nath SK, Scanderbeg D, et al. Evaluation of intra-and inter-fraction movement of the cervix during intensity modulated radiation therapy[J]. Radiother Oncol, 2011, 98(3):347-351. DOI:10.1016/j.radonc.2010.11.015.
2021, Vol. 30 
